Filana Therapeutics (SAVA) Q3 2025 Earnings

14AugConfirmed
Q3 2024
Q1 2025
Q2 2025
Q3 2025
-0.92
-0.77
-0.63
-0.48

Details

Expected EPS
N/A
Actual EPS
-0.92
Surprise EPS
-0.92
Surprise Percent
+∞%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.92 per share for Q3 2025.

0 Comments

Share your thoughts